The PLK4 expression may be negatively regulated by DNA methylation levels and miRNA expression and is associated with immune cell infiltration and exerting immunosuppressive cytokines; thus, PLK4 may be a potential target for clinical treatment of ccRCC. The gene discussed is PLK4; the disease is nonpapillary renal cell carcinoma.